Arnould Laurent, Penault-Llorca Frédérique, Dohollou Nadine, Caron Olivier, Levy Christelle
Département de biologie et de pathologie des tumeurs, Centre Georges-François-Leclerc, 21000 Dijon.
Département de pathologie, Centre Jean-Perrin, 63011 Clermont-Ferrand.
Bull Cancer. 2019 Dec;106(12S1):S10-S18. doi: 10.1016/S0007-4551(20)30042-4.
Early-onset of breast cancer (under the age of 40) represents only 7% of all breast cancers, but is the most common cancer in this age group in women. It is also known to be of worse prognosis, with a more aggressive tumoral behavior. The interaction of different prognostic factors contributes to the complexity of this population: tumor burden and biological features (using classical histopronostic features and genomic data) show differences from older women. Nevertheless, the prognostic impact of age varies according to the histological subtypes and seems pejorative mainly for the luminal subtype, probably with a crucial role of the hormonal environment and the treatments targeting the endocrine sensitivity of these tumors. In other subtypes, the influence of young age appears to be less significant, especially in HER2+ breast cancers.
早发性乳腺癌(40岁以下)仅占所有乳腺癌的7%,却是该年龄组女性中最常见的癌症。早发性乳腺癌也被认为预后较差,肿瘤行为更具侵袭性。不同预后因素之间的相互作用导致了这一人群情况的复杂性:肿瘤负荷和生物学特征(使用经典的组织预后特征和基因组数据)与老年女性存在差异。然而,年龄的预后影响因组织学亚型而异,似乎主要对管腔亚型不利,这可能与激素环境以及针对这些肿瘤内分泌敏感性的治疗方法的关键作用有关。在其他亚型中,年轻的影响似乎不那么显著,尤其是在HER2+乳腺癌中。